Jun 2026 (Q3 FY26) — Jul 29, 2026
Ashland Q3 FY26 — Strong Sales Growth and Operational Momentum
Read the full callAshland (ASH) earnings
- Jun 2026
- Jun 2026 (Q3 FY26)
- Sep 2025
Ashland earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 497 | +7.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 8.7 | +161.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. |
Price
$71.59 +0.38% · +$0.27
Performance +46.1% 1Y
1Y: $49.01 on 14 Oct 2025 → $71.59. High $76.45 (7 Aug 2026), low $47.84 (4 Nov 2025).
- Previous close
- $71.32
- 52-week range
- $47.84 – $76.45
- One year
- +46.04%
Overview
- Symbol
- ASH
- Sector
- Materials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Ashland earnings calls (ASH)
Financials
What the filings say
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 521 | 405 | 479 | 463 | 477 | 386 | 482 | 497 |
| Operating profit | 32 | -179 | 51 | -708 | 61 | -6 | 39 | 43 |
| Operating margin | 6.1% | −44.2% | 10.7% | −152.9% | 12.8% | −1.6% | 8.1% | 8.7% |
| Profit before tax | 25 | -209 | 39 | -704 | 65 | -15 | 20 | 56 |
| Tax rate | 24.0% | 20.6% | 23.1% | −2.1% | 49.2% | 6.7% | 25.0% | 26.8% |
| EPS ($ per share) | — | -3.50 | 0.65 | -16.21 | — | -0.26 | 0.34 | 0.35 |
| Line item | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 2,750 | 3,224 | 2,649 | 2,796 | 3,653 | 3,595 | 3,315 | 2,298 |
| Total liabilities | 4,853 | 3,680 | 3,841 | 3,860 | 2,993 | 2,842 | 2,777 | 2,707 |
| Fixed assets | 1,646 | 1,577 | 1,485 | 1,427 | 1,338 | 1,373 | 1,303 | 1,201 |
| Total assets | 8,259 | 7,251 | 6,877 | 6,612 | 6,213 | 5,939 | 5,645 | 4,611 |
| Line item | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 241 | 140 | 227 | 466 | 193 | 294 | 462 | 134 |
| Cash from investing | — | — | — | — | — | -109 | -51 | -3 |
| Cash from financing | -368 | -1,149 | 9 | -426 | -896 | -371 | -479 | -179 |
| Net cash flow | -272 | -62 | 222 | -244 | 436 | -229 | -117 | -85 |
| Capital expenditure | -157 | -147 | -133 | -105 | -113 | -170 | -137 | -98 |
| Free cash flow | 84 | -7 | 94 | 361 | 80 | 124 | 325 | 36 |
Insider filings
54 filings between Nov 13, 2025 and Sep 21, 2026.
Open market
decisions to buy or sellNobody bought or sold ASH on the open market in this window. The filings below are 28 option exercises and 26 tax withholdings.
Compensation
not trading decisions- 28
- Option exercise — converted options into shares
- 26
- Tax withheld — shares kept back by the company to cover tax
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | MUSA OSAMA M SVP and CTO | Tax withheld | 3,647 | $251.9K |
| Sep 21, 2026 | MUSA OSAMA M SVP and CTO | Option exercise | 10,418 | $719.5K |
| Aug 11, 2026 | LAMPKIN ROBIN E. SVP, GC & Secretary | Tax withheld | 526 | $39.2K |
| Aug 11, 2026 | LAMPKIN ROBIN E. SVP, GC & Secretary | Option exercise | 1,806 | $134.7K |
| Jul 29, 2026 | MUSA OSAMA M SVP and CTO | Option exercise 10b5-1 plan | 1,267 | $73.4K |
| Jul 27, 2026 | Assis Alessandra Faccin SVP and GM, Life Sciences | Option exercise | 3,215 | $213.4K |
| Jul 27, 2026 | Assis Alessandra Faccin SVP and GM, Life Sciences | Tax withheld | 884 | $58.7K |
| May 8, 2026 | MINICUCCI JAMES P. SVP and GM, Personal Care | Tax withheld | 1,346 | $74.0K |
| May 8, 2026 | MINICUCCI JAMES P. SVP and GM, Personal Care | Option exercise | 4,310 | $237.1K |
| Jan 21, 2026 | Kulkarni Ashish K Director | Option exercise | 2,113 | $0 |
| Nov 17, 2025 | WHITAKER WILLIAM SVP, CFO & PFO | Tax withheld | 33 | $1.6K |
| Nov 17, 2025 | RICHARDSON SAMUEL VP, Controller and PAO | Tax withheld | 32 | $1.6K |
| Nov 17, 2025 | Drury Eileen SVP and Chief HRO | Option exercise | 567 | $28.1K |
| Nov 17, 2025 | WHITAKER WILLIAM SVP, CFO & PFO | Option exercise | 107 | $5.3K |
| Nov 17, 2025 | Drury Eileen SVP and Chief HRO | Tax withheld | 280 | $13.9K |
| Nov 17, 2025 | MUSA OSAMA M SVP and CTO | Tax withheld | 335 | $16.6K |
| Nov 17, 2025 | LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. | Option exercise | 239 | $11.9K |
| Nov 17, 2025 | LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. | Tax withheld | 72 | $3.6K |
| Nov 17, 2025 | NOVO GUILLERMO Chair of the Board and CEO | Tax withheld | 2,563 | $127.1K |
| Nov 17, 2025 | NOVO GUILLERMO Chair of the Board and CEO | Option exercise | 6,122 | $303.7K |
| Nov 17, 2025 | RICHARDSON SAMUEL VP, Controller and PAO | Option exercise | 107 | $5.3K |
| Nov 17, 2025 | MUSA OSAMA M SVP and CTO | Option exercise | 976 | $48.4K |
| Nov 14, 2025 | MUSA OSAMA M SVP and CTO | Option exercise | 2,091 | $107.7K |
| Nov 14, 2025 | MUSA OSAMA M SVP and CTO | Tax withheld | 717 | $36.9K |
| Nov 14, 2025 | WHITAKER WILLIAM SVP, CFO & PFO | Option exercise | 356 | $18.3K |
| Nov 14, 2025 | RICHARDSON SAMUEL VP, Controller and PAO | Tax withheld | 69 | $3.6K |
| Nov 14, 2025 | RICHARDSON SAMUEL VP, Controller and PAO | Option exercise | 228 | $11.7K |
| Nov 14, 2025 | NOVO GUILLERMO Chair of the Board and CEO | Tax withheld | 3,817 | $196.6K |
| Nov 14, 2025 | NOVO GUILLERMO Chair of the Board and CEO | Option exercise | 9,119 | $469.7K |
| Nov 14, 2025 | Drury Eileen SVP and Chief HRO | Tax withheld | 603 | $31.1K |
| Nov 14, 2025 | Drury Eileen SVP and Chief HRO | Option exercise | 1,297 | $66.8K |
| Nov 14, 2025 | MINICUCCI JAMES P. SVP and GM, Personal Care | Tax withheld | 383 | $19.7K |
| Nov 14, 2025 | MINICUCCI JAMES P. SVP and GM, Personal Care | Option exercise | 1,225 | $63.1K |
| Nov 14, 2025 | LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. | Tax withheld | 381 | $19.6K |
| Nov 14, 2025 | WHITAKER WILLIAM SVP, CFO & PFO | Tax withheld | 108 | $5.6K |
| Nov 14, 2025 | LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. | Option exercise | 1,276 | $65.7K |
| Nov 13, 2025 | MUSA OSAMA M SVP and CTO | Option exercise | 1,393 | $74.0K |
| Nov 13, 2025 | MUSA OSAMA M SVP and CTO | Tax withheld | 477 | $25.3K |
| Nov 13, 2025 | WHITAKER WILLIAM SVP, CFO & PFO | Tax withheld | 70 | $3.7K |
| Nov 13, 2025 | WHITAKER WILLIAM SVP, CFO & PFO | Option exercise | 229 | $12.2K |
| Nov 13, 2025 | LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. | Tax withheld | 259 | $13.8K |
| Nov 13, 2025 | LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. | Option exercise | 866 | $46.0K |
| Nov 13, 2025 | RICHARDSON SAMUEL VP, Controller and PAO | Tax withheld | 44 | $2.3K |
| Nov 13, 2025 | NOVO GUILLERMO Chair of the Board and CEO | Tax withheld | 3,779 | $200.7K |
| Nov 13, 2025 | NOVO GUILLERMO Chair of the Board and CEO | Option exercise | 9,029 | $479.4K |
| Nov 13, 2025 | Drury Eileen SVP and Chief HRO | Tax withheld | 400 | $21.2K |
| Nov 13, 2025 | Drury Eileen SVP and Chief HRO | Option exercise | 863 | $45.8K |
| Nov 13, 2025 | MINICUCCI JAMES P. SVP and GM, Personal Care | Tax withheld | 319 | $16.9K |
| Nov 13, 2025 | MINICUCCI JAMES P. SVP and GM, Personal Care | Option exercise | 1,020 | $54.2K |
| Nov 13, 2025 | Assis Alessandra Faccin SVP and GM, Life Sciences | Tax withheld | 570 | $30.3K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for ASHLAND INC.
Free account. Everything above stays public.
Write why you follow ASHLAND INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading